Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment.

MLA

Dhas, Namdev, et al. “Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment.” Frontiers in Bioscience (Landmark Edition), vol. 29, no. 10, Oct. 2024, p. 349. EBSCOhost, https://doi.org/10.31083/j.fbl2910349.

APA

Dhas, N., Kudarha, R., Kulkarni, S., Soman, S., Navti, P. D., Kulkarni, J., Roy, A. A., Colaco, V., Raychaudhuri, R., Gupta, A., Pardeshi, C., Bari, D., Tiwari, R., Patel, J., Moorkoth, S., & Mutalik, S. (2024). Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment. Frontiers in Bioscience (Landmark Edition), 29(10), 349. https://doi.org/10.31083/j.fbl2910349

Chicago

Dhas, Namdev, Ritu Kudarha, Sanjay Kulkarni, Soji Soman, Prerana D Navti, Jahnavi Kulkarni, Amrita Arup Roy, et al. 2024. “Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment.” Frontiers in Bioscience (Landmark Edition) 29 (10): 349. doi:10.31083/j.fbl2910349.